• A long-standing federal law that makes it mandatory for employees, who work for all but the smallest employers, be given the option to continue their group insurance, upon leaving the job for whatever reason, for a certain period of time—typically 18 months (29 months if you are disabled) —at your expense. 
  • Many states have extended COBRA benefits to small employers as well. Check with your state insurance department.
  • When your COBRA option ends (or if you're never eligible for COBRA), you're then eligible to continue coverage under the newer Federal HIPAA law.
  • Usually, if you have Parkinson’s, your best option when leaving a job, is to first elect the COBRA option and then later the HIPAA option because you don’t have to qualify medically for either.
  • However if you are married and your spouse has their own job and their own group health coverage, you generally have the right under the law, if you apply within 30 days of losing your group coverage, to be added to your spouse’s coverage with no exclusion for preexisting medical problems.

Content for this section provided by Jack Hungelmann, who has had PD since 1996.


Sign Up for Resources on Living Well with PD

Get the latest on maintaining and improving your quality of life with Parkinson’s disease — straight to your inbox. Sign up for email updates now.

Please enter a valid email

Skip step

Invalid year format. Eg: 2020
Skip step
Skip step

*Please note that not all content is available in both languages. If you are interested in receiving Spanish communications, we recommend selecting “both" to stay best informed on the Foundation's work and the latest in PD news.

Skip step

Thanks for Signing Up

We are proud to have you as a part of our community. To ensure you receive the latest Parkinson’s news, research updates and more, please check your email for a message from us. If you do not see our email, it may be in your spam folder. Just mark as “not spam” and you should receive our emails as expected.

mail icon

Subscribe here to get the latest news on treatments, research and other updates.